Right Issue Ann from yesterday
"Given the interest of Onyx in supporting this trial Patrys will not be actively seeking a licensing partner for PAT-SM6 at this time."
"iv. Fund activities related to potential partnering/out-licensing of PAT-SM6."
PAB is looking to out-license SM6 if it all goes well.
Onyx is interested. They are paying for the trial but we needed to provide the drug (that's why we needed more money). PAB is not actively seeking another licensing partner because of ONYX's interest.
That's the bigger picture here.
how low tomorrow, page-17
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 5492487 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1636778 | 2 |
View Market Depth
| Last trade - 10.19am 10/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable